Opdivo/Cabometyx combo hits targets in first-line kidney cancer
admin 21st April 2020 Uncategorised 0The combination significantly increased progression free survival when used as a first-line treatment
More: Opdivo/Cabometyx combo hits targets in first-line kidney cancer
Source: News